Page last updated: 2024-10-21

8-(4-sulfophenyl)theophylline and Cardiomegaly

8-(4-sulfophenyl)theophylline has been researched along with Cardiomegaly in 1 studies

8-(4-sulfophenyl)theophylline: adenosine antagonist

Cardiomegaly: Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wakeno, M1
Minamino, T1
Seguchi, O1
Okazaki, H1
Tsukamoto, O1
Okada, K1
Hirata, A1
Fujita, M1
Asanuma, H1
Kim, J1
Komamura, K1
Takashima, S1
Mochizuki, N1
Kitakaze, M1

Other Studies

1 other study available for 8-(4-sulfophenyl)theophylline and Cardiomegaly

ArticleYear
Long-term stimulation of adenosine A2b receptors begun after myocardial infarction prevents cardiac remodeling in rats.
    Circulation, 2006, Oct-31, Volume: 114, Issue:18

    Topics: 2-Chloroadenosine; Acetamides; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; An

2006